Norgine Pharmaceuticals is a specialty pharmaceutical firm that develops, manufactures, and markets medications for treating acute and chronic illnesses. Its core focus is on gastroenterology, hepatology, pain management, and incontinence. Its bestselling drug, Movicol (for constipation), brings in more than half of its sales. Its fastest growing treatment is Xifaxan (for traveler's diarrhea and hepatic encephalopathy). Other products include procedural bowel cleansing therapy Moviprep and constipation treatment Normacol. Norgine Pharmaceuticals is a subsidiary of Netherlands-based Norgine BV, which was founded in 1906 and operates manufacturing facilities in France and the UK.